These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15831924)

  • 1. Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects.
    Foligné B; Grangette C; Pot B
    Gut; 2005 May; 54(5):727-8. PubMed ID: 15831924
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
    Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
    Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics in inflammatory bowel disease: yet another mechanism of action?
    Fiocchi C
    Gastroenterology; 2006 Dec; 131(6):2009-12. PubMed ID: 17188964
    [No Abstract]   [Full Text] [Related]  

  • 4. Homeostatic effects of TLR9 signaling in experimental colitis.
    Lee J; Rachmilewitz D; Raz E
    Ann N Y Acad Sci; 2006 Aug; 1072():351-5. PubMed ID: 17057215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease, a dysregulated host-microbiota interaction: are probiotics a new therapeutic option?
    Howarth GS
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1777-9. PubMed ID: 19120868
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation.
    Kim N; Kunisawa J; Kweon MN; Eog Ji G; Kiyono H
    Clin Immunol; 2007 Apr; 123(1):30-9. PubMed ID: 17218154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effect of yoghurt in an experimental inflammatory bowel disease in mouse.
    Gobbato N; Rachid M; Perdigón G
    J Dairy Res; 2008 Nov; 75(4):497-504. PubMed ID: 19032800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
    Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y
    Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.
    Dalmasso G; Cottrez F; Imbert V; Lagadec P; Peyron JF; Rampal P; Czerucka D; Groux H; Foussat A; Brun V
    Gastroenterology; 2006 Dec; 131(6):1812-25. PubMed ID: 17087945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics: do they help to control intestinal inflammation?
    Böhm SK; Kruis W
    Ann N Y Acad Sci; 2006 Aug; 1072():339-50. PubMed ID: 17057214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prebiotics in inflammatory bowel diseases.
    Guarner F
    Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics in experimental and human inflammatory bowel disease: discussion points.
    Pagnini C; Cominelli F
    Dig Liver Dis; 2006 Dec; 38 Suppl 2():S270-3. PubMed ID: 17259089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases.
    Nones K; Dommels YE; Martell S; Butts C; McNabb WC; Park ZA; Zhu S; Hedderley D; Barnett MP; Roy NC
    Br J Nutr; 2009 Jan; 101(2):169-81. PubMed ID: 18761777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.
    Pender SL; Chance V; Whiting CV; Buckley M; Edwards M; Pettipher R; MacDonald TT
    Gut; 2005 Aug; 54(8):1114-20. PubMed ID: 16009684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.